T
Thomas P. Johnston
Researcher at University of Missouri–Kansas City
Publications - 132
Citations - 3591
Thomas P. Johnston is an academic researcher from University of Missouri–Kansas City. The author has contributed to research in topics: Cholesterol & Hyperlipidemia. The author has an hindex of 30, co-authored 132 publications receiving 2399 citations.
Papers
More filters
Journal ArticleDOI
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Amir Tajbakhsh,Seyed Mohammad Gheibi Hayat,Hajar Taghizadeh,Ali Akbari,Masoumeh Inabadi,Amir Savardashtaki,Thomas P. Johnston,Amirhossein Sahebkar,Amirhossein Sahebkar +8 more
TL;DR: It is suggested that heart injury caused by CO VID-19 infection might be an important cause of severe clinical phenotypes or adverse events in affected patients, and early measurements of cardiac damage via biomarkers following hospitalization for COVID-19 infections in a patient with preexisting CVD are recommended.
Journal ArticleDOI
Curcumin: A natural modulator of immune cells in systemic lupus erythematosus.
Amir Abbas Momtazi-Borojeni,Saeed Mohammadian Haftcheshmeh,Seyed-Alireza Esmaeili,Thomas P. Johnston,Elham Abdollahi,Amirhossein Sahebkar +5 more
TL;DR: The results of in vitro, experimental, and clinical studies pertaining to the modulatory effects that curcumin produces on the function and numbers of dendritic cells and T cell subsets, as well as relevant cytokines that participate in SLE are reviewed.
Journal ArticleDOI
Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
Khadijeh Koushki,Sanaz Keshavarz Shahbaz,Kazem Mashayekhi,Mahvash Sadeghi,Zeinab Deris Zayeri,Mahdieh Yousefi Taba,Maciej Banach,Khalid Al-Rasadi,Thomas P. Johnston,Amirhossein Sahebkar +9 more
TL;DR: Statins are cost-effective drugs, which should have a continued future in the treatment of atherosclerosis due to both their immune-modulating and lipid-lowering effects.
Journal ArticleDOI
Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations.
TL;DR: This paper examines manufacturing and formulation variables that can affect drug bioavailability, and the potential for species-specific differences in the responses to these formulations.
Journal ArticleDOI
Curcumin, hemostasis, thrombosis, and coagulation
Faeze Keihanian,Amin Saeidinia,Ramin Khameneh Bagheri,Thomas P. Johnston,Amirhossein Sahebkar +4 more
TL;DR: Previous studies in the literature, which support the positive activity of curcumin in hemostasis, anticoagulation, and fibrinolysis, are reviewed and molecular mechanisms associated with the antiplatelet and antICOagulant activities ofCurcumin are presented.